Concepedia

Publication | Open Access

Long-term Efficacy, Safety, and Immunogenicity of Biosimilar Infliximab After One Year in a Prospective Nationwide Cohort

DOIFull Paper Access

56

Citations

26

References

2017

Year

Lóránt Gönczi, K Gecse, Zsuzsanna Végh, Zsuzsanna Kürti, Mariann Rutka, Klaudia Farkas, Petra A. Golovics, Barbara D. Lovász, János Banai, László Bene,
Inflammatory Bowel Diseases

Abstract

Results from this prospective nationwide cohort confirm that CT-P13 is effective and safe in inducing and maintaining long-term remission in both CD and UC. Efficacy was influenced by previous anti-TNF exposure; no new safety signals were detected.

References

YearCitations

Page 1